Target intelligence / Profile preview

WDR81 antisense RNA 1 (WDR81-AS1)

Target: WDR81-AS1
Molecular classification: Long non-coding RNA, Antisense RNA

Overview

WDR81 antisense RNA 1 (WDR81-AS1, also lnc-TLCD2-1) is a long non-coding RNA transcribed antisense to the WDR81 protein coding gene. It is formally classified as an "antisense RNA" and belongs to the family of long non-coding RNAs, which are defined by transcripts >200 nucleotides with no protein-coding capacity[4]. The biological role of WDR81-AS1 has not been clearly delineated, but, by analogy to other antisense lncRNAs, it may participate in the regulation of neighboring gene expression, chromatin structure, or epigenetic modification[3][4]. There is currently no evidence of WDR81-AS1 as a direct therapeutic target, disease biomarker, or drug interaction partner. Further functional and mechanistic studies would be needed to establish any disease involvement, druggability, or clinical relevance.

Other names: lnc-TLCD2-1WDR81-AS1

Biological functions

Likely involved in regulation of gene expression (antisense regulation of WDR81)Potential role in chromatin modification and epigenetic regulation (general function of antisense lncRNAs)Other (specific functions of WDR81-AS1 remain to be elucidated)

Disease associations

Other (There is currently no directly validated disease association for WDR81-AS1. However, lncRNAs often participate in cancer, neurodegeneration, and other complex diseases. No published evidence for direct involvement of WDR81-AS1 in a particular disease was found in the results.)

Beyond the preview

Go deeper on WDR81 antisense RNA 1 (WDR81-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WDR81 antisense RNA 1 (WDR81-AS1).

Explore the full profile